Freidoun Albertioni

On the bioavailability of oral and subcutaneous 2-chloro-2'-deoxyadenosine in humans: alternative routes of administration.

Jan Liliemark, Freidoun Albertioni, Moustapha Hassan et al. · Journal of Clinical Oncology · 1992 · 130 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia.

Gunnar Juliusson, Dag Heldal, Erik Hippe et al. · Journal of Clinical Oncology · 1995 · 103 citations

Medicine, Hematology, Pharmacology +15

Clinical and Pharmacokinetic Risk Factors for High-dose Methotrexate-induced Toxicity in Children with Acute Lymphoblastic Leukemia: A Logistic Regression Analysis

Charlotte Ulrikka Rask, Freidoun Albertioni, Søren M. Bentzen et al. · Acta Oncologica · 1998 · 101 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, a novel analogue of cladribine in human leukemic cells.

Kourosh Lotfi, Emma Månsson, Tatjana Spasokoukotskaja et al. · PubMed · 1999 · 88 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance

Emma Månsson, Emma Flordal, Jan Liliemark et al. · Biochemical Pharmacology · 2002 · 83 citations

Medicine, Oncology, Pharmacology +12